Generative AI (Gen AI) is significantly impacting healthcare, with investments exceeding USD 1.7 billion in AI-driven drug discovery and other areas. This AI can process vast amounts of unstructured data, enhancing diagnostics, administrative tasks, and drug research. However, concerns about risk, privacy, and security are growing as Gen AI integration deepens. Effective guidelines and robust frameworks, like the EDGE Framework, are crucial for ensuring privacy and compliance. Gen AI promises enhanced clinical operations, personalized patient care, and streamlined administrative processes, potentially unlocking USD 1 Trillion in industry improvements.

Join for free to read